Ligases are enzymes that join molecules together by forming new chemical bonds, and they are involved in nearly every major process inside a living cell. From sealing breaks in DNA after replication to attaching amino acids to transfer RNA for protein synthesis, ligases keep biological machinery running. The enzyme class is broader than most people realize: it includes not just the DNA ligases familiar from molecular biology courses but also ubiquitin ligases that tag proteins for destruction, metabolic enzymes that build key intermediates, and engineered variants that power modern genomics tools. Understanding what ligases do, how they differ from one another, and why scientists care so much about them opens a window into both fundamental biology and practical biotechnology.
How Ligases Join Molecules Together
All ligases share a basic job description: they catalyze the formation of a covalent bond between two substrates, and they pay for that bond with the energy stored in a nucleotide triphosphate, usually ATP. The details vary depending on the ligase family, but the principle is consistent. The enzyme first activates itself (or one of its substrates) using the energy donor, creating a reactive intermediate. That intermediate then transfers its stored energy to drive the bond-forming step.
DNA ligases offer the clearest illustration of this logic. The reaction proceeds through three chemical steps. First, the ligase reacts with ATP (or, in bacteria, with NAD+) to form a covalent enzyme-AMP intermediate, releasing pyrophosphate or nicotinamide mononucleotide in the process. Second, the AMP group is transferred from the enzyme onto the 5′-phosphate end of a DNA nick, creating a DNA-adenylate intermediate. Third, the neighboring 3′-hydroxyl group attacks the DNA-adenylate, sealing the nick with a new phosphodiester bond and releasing AMP.1Journal of Biological Chemistry. Crystal structures of ATP-dependent DNA ligase D in complexes with ATP and magnesium reveal a two-metal mechanism of lysine adenylylation Each step is distinct and tightly controlled, requiring a divalent metal ion cofactor, typically magnesium, to position the substrates and stabilize reaction intermediates.2PubMed Central. Two-metal versus one-metal mechanisms of lysine adenylylation by ATP-dependent and NAD(+)-dependent polynucleotide ligases
This three-step mechanism has been confirmed across multiple DNA ligase families. Studies of human DNA ligase I, for example, show that magnesium concentration affects which of the three steps becomes rate-limiting, which can compromise overall ligation efficiency when conditions are not ideal.3PubMed Central. Kinetic mechanism of human DNA ligase I reveals magnesium-dependent changes in the rate-limiting step that compromise ligation efficiency The stepwise nature of the reaction also means the enzyme can stall partway through if its active site is disrupted, a finding that has proven useful for designing inhibitors.
DNA Ligases in Human Cells
Humans encode three DNA ligase genes, LIG1, LIG3, and LIG4, and each serves distinct roles in replication and repair.4PubMed Central. Human DNA ligases in replication and repair DNA ligase I handles the bulk of the work during DNA replication, sealing the short Okazaki fragments on the lagging strand into a continuous new strand. DNA ligase III participates in base excision repair and mitochondrial DNA maintenance. DNA ligase IV is dedicated to non-homologous end joining, the primary pathway cells use to repair double-strand breaks, and it also plays an essential role during immune cell development by joining gene segments in the process that generates antibody diversity.
The division of labor matters clinically. When DNA ligase IV is impaired by mutations in LIG4, patients develop a condition known as DNA Ligase IV syndrome. The hallmarks include severe sensitivity to ionizing radiation, primordial growth failure with pronounced microcephaly, a spectrum of learning difficulties, bone marrow hypoplasia, and a predisposition to lymphoid malignancies.5PubMed Central. DNA ligase IV syndrome; a review Patients with mutations in this gene show impaired double-strand break rejoining and abnormal immune receptor rearrangement, which explains both the immunodeficiency and the developmental features.6PubMed. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency Regulation of DNA ligase IV stability is itself complex: the protein kinase DNA-PK phosphorylates it, and the protein’s stability depends on its interaction with the cofactor XRCC4, its phosphorylation status, and possibly its conformational state.7Journal of Biological Chemistry. Phosphorylation and Regulation of DNA Ligase IV Stability by DNA-dependent Protein Kinase
RNA Ligases and tRNA Repair
RNA ligases are less well known than their DNA counterparts, but they carry out equally important work. The enzymes that phosphorylate, dephosphorylate, and ligate RNA ends were discovered more than fifty years ago, though researchers only gradually figured out that these enzymes repair deliberate, site-specific cuts in the RNA backbone.8PubMed. RNA Repair: Hiding in Plain Sight The best-studied example is tRNA splicing, where introns are cut out of precursor tRNAs and the remaining fragments are rejoined by an RNA ligase.
Bacteriophage T4 RNA ligase 1 (Rnl1) provides a vivid case. It acts as a tRNA repair enzyme during viral infection, counteracting a host defense that damages tRNAs to shut down translation. Rnl1 has an inherent specificity for sealing tRNA molecules with a break in the anticodon loop, the region the host endonuclease targets.9PubMed Central. The C-terminal domain of T4 RNA ligase 1 confers specificity for tRNA repair This is a miniature arms race at the molecular level: the bacterium breaks the virus’s tRNA, the virus ligase repairs it. The specificity of Rnl1 resides in its C-terminal domain, and researchers have been able to reprogram related bacterial RNA repair enzymes to redirect their tRNA-splicing activity by swapping domains.10PubMed Central. Reprogramming the tRNA-splicing activity of a bacterial RNA repair enzyme
Beyond their natural roles, RNA ligases have become indispensable laboratory tools. T4 RNA ligase is routinely used in protocols for small RNA cloning, adapter ligation in RNA sequencing, and construction of modified RNA molecules.
Ligases That Work Outside Nucleic Acids
The word “ligase” often evokes DNA and RNA, but the enzyme class is much broader. Any enzyme that joins two substrates using the hydrolysis of a nucleoside triphosphate qualifies, and several non-nucleic-acid ligases are central to metabolism.
Aminoacyl-tRNA synthetases are a universal family of ligases that attach amino acids to their matching tRNA molecules, a step essential for accurate protein synthesis. Each synthetase recognizes a specific amino acid and its cognate tRNA, ensuring that the genetic code is translated faithfully. These enzymes also proofread their own work, hydrolyzing incorrectly attached amino acids to prevent translation errors.11PubMed Central. Aminoacyl-tRNA synthetases
Pyruvate carboxylase is another ligase, though it is rarely thought of that way. This biotin-containing enzyme catalyzes the ATP-dependent carboxylation of pyruvate to form oxaloacetate, a key intermediate that feeds into both gluconeogenesis and the citric acid cycle.12PubMed Central. Structure, mechanism and regulation of pyruvate carboxylase Glutamate cysteine ligase, the enzyme that catalyzes the first and rate-limiting step in glutathione synthesis, offers yet another example. Its activity is tuned by a modifier subunit that adjusts the enzyme’s affinity for its substrates and its sensitivity to feedback inhibition by glutathione, and oxidative stress can dramatically alter the formation and activity of the active enzyme complex.13PubMed Central. Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase
Ubiquitin Ligases and Protein Turnover
Ubiquitin ligases, known as E3 ligases, are the specificity-determining components of the ubiquitin-proteasome system, the cell’s primary pathway for tagging unwanted or damaged proteins for degradation. The E3 ligase is the enzyme that physically transfers the small protein ubiquitin onto a target, marking it for destruction by the proteasome. Based on their structures and how they transfer ubiquitin, E3 ligases fall into four major types: HECT, RING-finger, U-box, and RBR. These families share little sequence similarity and differ substantially in composition, reflecting the enormous range of targets they recognize.14PubMed Central. E3 ubiquitin ligases: styles, structures and functions
The sheer number of E3 ligases encoded in the human genome (over 600 by most estimates) hints at how many cellular processes they govern. Misregulation of E3 ligases has been linked to cancer, neurodegeneration, and inflammatory disease, making them attractive drug targets. One of the most exciting recent developments is the use of E3 ligases in a drug-design strategy called targeted protein degradation, discussed in more detail below.
Ligases as Laboratory Workhorses
T4 DNA ligase is arguably the most widely used enzyme in molecular biology after restriction enzymes and DNA polymerases. It seals both nicked DNA and blunt-ended fragments, though its efficiency varies with the type of DNA end. Comparative studies show that T4 DNA ligase has highest activity on blunt ends and two-base overhangs, with poorer performance on single-base 5′ overhangs.15PLoS ONE. Comparative analysis of the end-joining activity of several DNA ligases Adding crowding agents like polyethylene glycol (PEG) can boost both blunt-end and cohesive-end ligation rates by orders of magnitude, mimicking the molecular crowding inside a living cell.16PubMed Central. Polymer-stimulated ligation: enhanced blunt- or cohesive-end ligation of DNA or deoxyribooligonucleotides by T4 DNA ligase in polymer solutions
Ligases are also critical components of modern DNA assembly methods. Gibson isothermal assembly, one of the most popular techniques for building large DNA constructs, relies on three enzymes working together in a single tube at constant temperature: a 5′ exonuclease to chew back DNA ends, a high-fidelity polymerase to fill gaps, and Taq DNA ligase to seal the remaining nicks. The method allows researchers to stitch together multiple DNA fragments in one step without worrying about restriction-enzyme compatibility, making it especially powerful for synthetic biology projects that involve assembling entire metabolic pathways from individually synthesized genes.17Integrative Biology. DNA assembly for synthetic biology: from parts to pathways and beyond
In next-generation sequencing, ligation-based library preparation methods use ligases to attach sequencing adapters to DNA fragments. One such approach, called SRSLY, ligates custom adapters in a combined phosphorylation and ligation step that skips the usual end-polishing requirement, simplifying the workflow for analyzing cell-free DNA and synthetic oligonucleotides.18PubMed Central. A ligation-based single-stranded library preparation method to analyze cell-free DNA and synthetic oligos
Detecting Single-Base Mutations with Ligase Chain Reaction
One clever application of thermostable DNA ligases exploits their precision to detect genetic mutations. In the ligase chain reaction (LCR), two oligonucleotide probes are designed to sit side by side on a target DNA sequence. A thermostable ligase seals the junction between them only if the bases at that junction are perfectly matched to the target. A single mismatched base at the ligation point prevents the seal, so the reaction distinguishes a normal sequence from one carrying a point mutation. By cycling between high temperature (to melt the products off the target) and ligation temperature, the joined probes accumulate exponentially, much like PCR amplifies DNA.19PubMed. Genetic disease detection and DNA amplification using cloned thermostable ligase The thermostable ligase used in this assay was cloned specifically for the purpose of enabling high-temperature ligation cycling.20Gene. Cloning, overexpression and nucleotide sequence of a thermostable DNA ligase-encoding gene
LCR has been applied to the detection of single-base genetic diseases, pathogen identification, and genotyping. While PCR-based methods dominate clinical diagnostics today, ligase-based detection remains valuable in situations where the target variant is a single nucleotide change and high specificity is paramount.
Antibiotics That Target Bacterial Ligases
The distinction between ATP-dependent and NAD+-dependent DNA ligases is not just a biochemical curiosity. Bacteria rely on NAD+-dependent DNA ligase (LigA) for DNA repair and replication, while human cells use only ATP-dependent ligases. That difference creates a therapeutic window: a drug that blocks LigA should kill bacteria without harming human cells.
Researchers have pursued this idea with promising results. A class of substituted adenosine analogs was found to inhibit LigA enzymes from a range of pathogenic bacteria, including E. coli, Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae, with potency in the nanomolar range. These compounds showed no inhibitory activity against human DNA ligase I or T4 ligase, confirming selectivity for the bacterial enzyme. In mouse infection models, treatment with these adenosine analogs reduced bacterial burden as much as a thousandfold in infected tissue.21PubMed Central. Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo Further work on adenine-based inhibitors has explored the relationship between enzyme inhibition and actual antibacterial potency, finding that some compounds inhibit the enzyme in a test tube but fail to translate into antibacterial activity in certain species, a reminder that getting a drug into a bacterial cell is sometimes harder than designing one that works on the purified target.22ACS Medicinal Chemistry Letters. Antimicrobial Activity of Adenine-Based Inhibitors of NAD+-Dependent DNA Ligase
Targeted Protein Degradation Using E3 Ligases
One of the most exciting recent advances in drug discovery does not involve blocking an enzyme’s active site at all. Instead, it hijacks the cell’s own E3 ubiquitin ligases to destroy disease-causing proteins. The strategy uses molecules called PROTACs (proteolysis-targeting chimeras), which are bifunctional compounds with one end that binds the target protein and another end that recruits an E3 ligase. When the PROTAC brings the target and the ligase into proximity, the ligase tags the target with ubiquitin, and the proteasome degrades it.
A demonstration of this approach targeted BCR-ABL, the fusion protein that drives chronic myeloid leukemia. Researchers designed PROTAC molecules connecting dasatinib (a BCR-ABL inhibitor) to a ligand for the VHL E3 ubiquitin ligase. After extensive optimization of the chemical linker between the two binding ends, they identified a compound called SIAIS178 that induced effective degradation of BCR-ABL protein, inhibited the growth of BCR-ABL-positive leukemic cells in culture, and caused substantial tumor shrinkage in mice bearing human leukemia xenografts.23PubMed. Discovery of SIAIS178 as an Effective BCR-ABL Degrader by Recruiting Von Hippel-Lindau (VHL) E3 Ubiquitin Ligase This approach is attractive because a single PROTAC molecule can trigger destruction of many copies of the target protein through catalytic recycling, and it can eliminate proteins that traditional small-molecule inhibitors cannot effectively block.
The Evolutionary Split Between ATP and NAD+ Ligases
DNA ligases fall into two broad families defined by their energy source: ATP-dependent ligases, found mainly in eukaryotes and archaea, and NAD+-dependent ligases, found predominantly in bacteria. This split has long been considered a fundamental dividing line in biology, but the boundary turns out to be blurrier than textbooks suggest.
The halophilic archaeon Haloferax volcanii provided a surprise when researchers discovered it encodes an NAD+-dependent DNA ligase, the first identified in any archaeon. Phylogenetic analysis indicated that the gene was acquired from bacteria through lateral gene transfer.24PubMed. ATP- and NAD+-dependent DNA ligases share an essential function in the halophilic archaeon Haloferax volcanii Large DNA viruses of eukaryotes add further complexity. Phylogenetic reconstruction of ligases in these viruses reveals that NAD+-dependent ligases are encoded by a minority of the group but appear to be monophyletic, suggesting the enzyme was present in the ancestral virus and subsequently lost by most lineages. ATP-dependent ligases in the same viral group show a more tangled history, with no clear monophyly, pointing to multiple acquisitions or replacements over evolutionary time.25PubMed Central. Evolution of DNA ligases of nucleo-cytoplasmic large DNA viruses of eukaryotes: a case of hidden complexity
This evolutionary patchwork matters practically. The assumption that NAD+-dependent ligases are exclusive to bacteria underpins antibiotic strategies targeting LigA. While that assumption holds for human cells, the presence of NAD+-dependent ligases in some archaea and viruses is a reminder that gene transfer has blurred neat taxonomic lines.
Engineered and Artificial Ligases
Scientists are not limited to the ligases nature provides. Efforts to create artificial ligases from scratch, or to evolve existing ones toward new functions, are pushing the boundaries of what catalytic molecules can do.
One line of work involves ribozymes, RNA molecules that catalyze chemical reactions. Researchers have used directed evolution in the lab to take a ligase ribozyme that originally used prebiotically relevant phosphorimidazole-activated substrates and evolve it to catalyze ligation with triphosphate-activated substrates, the form used in modern biology.26PubMed Central. Evolution of the substrate specificity of an RNA ligase ribozyme from phosphorimidazole to triphosphate activation This kind of experiment bears directly on questions about the origin of life, testing whether primitive RNA catalysts could have transitioned to using the same chemical activation strategies that cells use today.
Another approach produces aptazymes, hybrid molecules that combine a catalytic ribozyme with an aptamer (a structure that binds a specific small molecule). By grafting an ATP-binding aptamer onto a ligase ribozyme, researchers created a construct whose ligation activity increased roughly 30-fold in the presence of ATP, effectively building a molecular switch that ligates RNA only when the right chemical signal is present.27Nucleic Acids Research. Design and optimization of effector-activated ribozyme ligases Separately, DNAzymes, catalytic DNA molecules, have been engineered to perform RNA ligation. Computational and experimental studies of the 9DB1 DNAzyme have revealed that its ligation mechanism resembles that of cellular polymerases, an intriguing convergence given that DNA and protein catalysts share no structural ancestry.28Nature Catalysis. An artificial DNAzyme RNA ligase shows a reaction mechanism resembling that of cellular polymerases
These engineered systems are not just academic curiosities. Aptazyme-based ligases could serve as biosensors that produce a signal only in the presence of a target molecule, while DNAzyme ligases offer stability advantages over protein enzymes in harsh conditions. As the toolkit of artificial ligases grows, the range of applications, from diagnostics to therapeutic RNA manipulation, will likely expand with it.